GO
Loading...

Health Care Providers and Services

More

  • AstraZeneca Chair: Shareholders, 'vote me away' Monday, 19 May 2014 | 11:14 AM ET

    As AstraZeneca's shares slid following its rejection of Pfizer's new bid, the company's chairman said he was "reasonably confident" it was the right decision.

  • NEW YORK, May 16- American Realty Capital Healthcare Trust Inc is in exclusive talks to buy Griffin-American Healthcare REIT II Inc, a deal that could value the healthcare real-estate investment trust at around $3.7 billion, according to people familiar with the matter.

  • May 15- Consumers who purchased new health plans from Blue Shield of California have sued the insurer, claiming they were misled into thinking the insurance would cover their desired doctors and hospitals.

  • *Offers $14/ shr in cash and stock, 64 pct premium. May 15- Hospital operator Kindred Healthcare Inc went hostile with its $533 million offer for Gentiva Health Services Inc on Thursday, after Gentiva rejected the bid saying it expected to generate more value as a standalone provider of home healthcare services.

  • May 15- Kindred Healthcare Inc said it offered to buy home healthcare services company Gentiva Health Services Inc for $533 million, but the bid was rejected by Gentiva as it expects to generate more value as a stand-alone company.

  • 2 Florida health workers ill after exposed to MERS Tuesday, 13 May 2014 | 11:43 AM ET
    This undated electron microscope image made available by the National Institute of Allergy and Infectious Diseases - Rocky Mountain Laboratories shows a novel coronavirus particle, also known as the MERS virus.

    Hospital officials say one of two healthcare workers exposed to the deadly MERS virus has been hospitalized.

  • May 6- Hospital operator Community Health Systems Inc reported a first-quarter net loss on Tuesday, reflecting the costs of acquiring smaller rival Health Management Associates.

  • April 29- Mortgage and life insurer Genworth Financial Inc reported a better-than-expected rise in quarterly profit, helped by a near-doubling in income from its long-term care insurance business. Genworth, spun off from General Electric Co a decade ago, had years ago written generous long-term care policies offering long periods of coverage.

  • April 29- Pharmacy benefit manager Express Scripts Holding Co on Tuesday posted a lower-than-expected first-quarter profit and decreased its earnings forecast for full-year 2014, saying adjusted prescription volume would be less than it had anticipated. Express Scripts shares fell 6 percent in extended trading.

  • LONDON, April 16- The European Medicines Agency warned on Wednesday that vials of Roche's breast cancer drug Herceptin, thought to have been stolen from hospitals in Italy, have been tampered with and reintroduced into the supply chain. In a separate statement Roche said that counterfeit Herceptin has been discovered in Britain, Finland and Germany.

  • April 14- China- focused hospital operator Chindex International Inc received a buyout offer of $23 per share, higher than the $19.50 offered by Shanghai Fosun Pharmaceutical Group and private equity firm TPG in February. Chindex, which runs the United Family Healthcare hospitals in China, did not name the new bidder.

  • March 29- Gilead Sciences Inc, under fire for pricing a new hepatitis C drug at $1,000 a pill, has discount agreements with a number of health insurers, a company executive said in an interview.

  • Treasury Secretary Jack Lew was running a mild fever and will stay in the hospital overnight on Tuesday after treatment for a benign enlarged prostate, a Treasury spokesperson said.

  • How Obamacare's making a $5.6 billion problem worse Wednesday, 12 Mar 2014 | 2:23 PM ET

    Criminal attacks on health-care providers increased dramatically—up 100 percent since 2010. And Obamacare may make it worse, according to a new study.

  • March 10- German health regulators have granted Northwest Biotherapeutics Inc special permission to sell its experimental brain cancer drug, DCVax-L, in the country, even though the small U.S. biotechnology company has not yet completed its late-stage trial of the immunotherapy.

  • NEW YORK, March 6- Shopping for employee health insurance on private marketplaces might be the way of the future for tens of millions. However, expert opinions about growth have been based on projections, not actual consumer behavior in the exchanges that only really got going last year.

  • Feb 27- Pharmacy benefit manager Catamaran Corp forecast full-year profit below analysts' estimates, sending its Toronto- listed shares down as much as 12 percent. The Schaumburg, Illinois- based company said it expected adjusted earnings of $2.04- $2.19 per share for 2014, which analysts said was probably due to lower margins.

  • Feb 24- Pfizer Inc said on Monday that Prevnar 13, its blockbuster vaccine against childhood infections, prevented pneumonia outside of hospitals in people age 65 and older, in one of the largest drug trials ever conducted.

  • PARIS, Feb 18- A patient with terminal heart failure is in "satisfactory condition" two months after becoming the first person to be fitted with Carmat's artificial heart which is designed to beat for several years, his hospital said.

  • Feb 11- Specialty pharmaceuticals company Mallinckrodt Plc said it would buy pain drug maker Cadence Pharmaceuticals Inc for about $1.3 billion to expand in the hospital market, where Cadence's products are widely used.